G1 Therapeutics Inc
Change company Symbol lookup
Select an option...
GTHX G1 Therapeutics Inc
CMS CMS Energy Corp
NVDA NVIDIA Corp
SBUX Starbucks Corp
EXEL Exelixis Inc
TSLA Tesla Inc
CGC Canopy Growth Corp
KHC Kraft Heinz Co
AMD Advanced Micro Devices Inc
X United States Steel Corp
Go

Health Care : Biotechnology | Company profile

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38 are designed to be combined and enhance the anti-tumor activity of current therapies. It is also developing G1T48, an oral selective estrogen receptor degrader (SERD) for the treatment of breast cancer. The Company is evaluating trilaciclib in three Phase II clinical trials. G1T38 is being evaluated in combination with Faslodex in a Phase I b/II a trial for patients with estrogen receptor-positive, HER2-negative breast cancer.

Price
Delayed
$21.59
Day's Change
-0.33 (-1.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
22.13
Day's Low
20.73
Volume
(Light)

Today's volume of 270,491 shares is on pace to be much lighter than GTHX's 10-day average volume of 413,525 shares.

270,491
  • Prev Close
    21.92
  • Today's Open
    21.78
  • Day's Range
    20.73-22.13
  • Avg Vol (10-day)
    413.5K
  • Last (time)
    3:44p ET 10/18/19
  • Last (size)
    100
  • 52-Wk Range
    13.87 - 48.43
    LowHigh
  • (10/19/18 - 03/25/19)
    55.66%
  • 103.9%
  • Market Cap
    810.1M
  • Shares Outstanding
    37.5M
  • -2.70
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 94.17
  • (% of float 09/30/19)
    12.57

Latest News

September 29, 2019
6:00 am ET
Globe Newswire
September 28, 2019
4:15 am ET
Globe Newswire
September 10, 2019
6:01 am ET
Globe Newswire
September 03, 2019
7:00 am ET
Globe Newswire
August 08, 2019
8:31 am ET
MarketWatch
August 07, 2019
4:01 pm ET
Globe Newswire
August 06, 2019
7:01 am ET
Globe Newswire
July 31, 2019
7:00 am ET
Globe Newswire
July 30, 2019
7:01 am ET
Globe Newswire
June 19, 2019
1:58 pm ET
MarketWatch
April 29, 2019
5:07 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.